Abstract
Type II diabetes mellitus (T2DM) and osteoarthritis (OA) are chronic
diseases that exhibit a strong relationship with age and obesity, and their co-existence
tends to be accompanied by more altered disease conditions. With the increase in
precision medicine, understanding the effect of common co-morbidities, such as
diabetes, should result in improved management of OA. A higher prevalence of OA has
been reported among patients with metabolic syndrome and diabetes mellitus (DM) and
is considered an independent predictor for OA. The review of the literature suggests
that DM may accelerate the symptoms, severity, and risk associated with joint
replacement. Also, clinical and laboratory studies have suggested that there is an
involvement of biochemical and biomechanical changes in articular cartilage in DM.
Thus, the molecular mechanism that is activated in a diabetes-like environment that
may contribute to OA could be characterized. Diabetes-influenced mechanism may
provide knowledge on disease etiopathology and an improved understanding of the
biological underpinning of disease for more specific therapeutic OA outcomes.
Keywords: Articular cartilage, Osteoarthritis, Type II diabetes mellitus.